CIM
CYTK icon

CIM Investment Management’s Cytokinetics CYTK Stock Holding History

CIM Investment Management’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$482K Buy
5,657
+979
+21% +$70.3K 0.12% 143
2026
Q1 		$308K Buy
+4,678
New +$297K 0.08% 194
2024
Q2 		– Sell
-3,156
Closed -$221K – 265
2024
Q1 		$221K Hold
3,156
– – 0.07% 242
2023
Q4 		$263K Buy
+3,156
New +$114K 0.08% 222

Other funds holding CYTK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CIM Investment Management's CYTK Position: Q2 2026 in Review

CIM Investment Management increased its Cytokinetics (CYTK) stake by 21% in Q2 2026, buying an estimated $70.3K and bringing the position to 5,657 shares worth $482K. The position accounts for 0.12% of the portfolio, ranked #143.

CIM Investment Management first reported a position in CYTK in Q4 2023 and has held it in 4 quarters since. 484 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

  • CIM Investment Management held 5,657 shares of Cytokinetics worth $482K as of Q2 2026.
  • CIM Investment Management bought 979 Cytokinetics shares in Q2 2026, an estimated $70.3K.
  • Cytokinetics made up 0.12% of CIM Investment Management's portfolio in Q2 2026, its #143 holding.
  • CIM Investment Management first reported a position in Cytokinetics in Q4 2023 and has held it in 4 quarters since.
  • 484 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on CIM Investment Management's 13F filing for Q2 2026, filed 29 Sep 2026.